Ascor® is McGuff Pharmaceuticals Inc.'s branded formula of Ascorbic Acid Injection, USP.
Ascor® is vitamin C indicated for the short term (up to 1 week) treatment of scurvy in adult and pediatric patients age 5 months and older for whom oral administration is not possible, insufficient or contraindicated.
Ascor® is not indicated for treatment of vitamin C deficiency that is not associated with signs and symptoms of scurvy.
McGuff Pharmaceutical's Ascor® consists of a 50mL pharmacy bulk package of sterile, preservative-free, pyrogen-free Ascorbic Acid, USP (500 mg/mL) in a solution containing Edetate Disodium (0.025%), Water for Injection (q.s.) and Sodium Bicarbonate for pH adjustment (pH 5.6 to 6.6).
Storage conditions for Ascorbic Acid Injection are not specified in the USP. McGuff Pharmaceuticals chose to have its product refrigerated to retard the accumulation of pressure and improves stability of product potency for up to 24 months.
McGuff Pharmaceuticals maintains a unique combination of technical capabilities, state of the art manufacturing facilities and strong supplier relationships to assure its goal of meeting patient and physician needs for high quality, competitively priced, small volume injectable products. The introduction of Ascor® demonstrates our commitment to these customers.
Ascor® is registered in the United States and may be pending or registered in other jurisdictions.